Literature DB >> 11924716

Discriminating factors for recurrent hypertension in patients with primary aldosteronism after adrenalectomy.

Yuji Fukudome1, Koji Fujii, Hisatomi Arima, Yusuke Ohya, Takuya Tsuchihashi, Isao Abe, Masatoshi Fujishima.   

Abstract

Patients with primary aldosteronism show relatively high rates of hypertension after adrenalectomy, but the risk factors for postoperative hypertension remain unclear. Forty-six patients with primary aldosteronism (PA) who had undergone adrenalectomy between 1976 and 1998 were enrolled in this study. Follow-up information including blood pressure (BP) and cardiovascular complications was collected by means of correspondence or telephone contact. At discharge BP was normalized in 34 patients (72%); hypertension persisted in the remaining 12 patients, but BP control was significantly improved. The patients who remained hypertensive at discharge had longer durations of hypertension than did those with normalized BP. After an average follow-up period of 12.2 years, 16 of 34 BP-normalized patients (47%) had recurrent hypertension. Age at adrenalectomy, preoperative serum creatinine level and systolic blood pressure at discharge were significantly higher in patients with recurrent hypertension than in those without it. A multivariate logistic regression analysis revealed that only the level of serum creatinine was independently associated with the incidence of recurrent hypertension. Patients with serum creatinine of 0.9 mg/dl or greater had significantly higher rates of recurrent hypertension than those with lower values of serum creatinine. Cardiovascular complications occurred in 5 patients prior to the surgery and in 2 patients during the follow-up period. Although the severity of renal involvement is subclinical, renal damage may play an important role in the development of hypertension during a long period after adrenalectomy in patients with PA.

Entities:  

Mesh:

Year:  2002        PMID: 11924716     DOI: 10.1291/hypres.25.11

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  11 in total

1.  [Primary hyperaldosteronism: should we pose its systematic detection at health centres?].

Authors:  C Maciá-Bobes; A Ronzón-Fernández; G Castaño-Fernández; P Botas-Cervero
Journal:  Aten Primaria       Date:  2006-02-15       Impact factor: 1.137

2.  Outcome of surgery for primary hyperaldosteronism.

Authors:  Jens Waldmann; Lisa Maurer; Julia Holler; Peter H Kann; Annette Ramaswamy; Detlef K Bartsch; Peter Langer
Journal:  World J Surg       Date:  2011-11       Impact factor: 3.352

3.  Long-term follow-up after adrenalectomy for primary aldosteronism.

Authors:  Andreas Meyer; Georg Brabant; Matthias Behrend
Journal:  World J Surg       Date:  2005-02       Impact factor: 3.352

Review 4.  Primary aldosteronism: from bench to bedside.

Authors:  Norlela Sukor
Journal:  Endocrine       Date:  2011-11-01       Impact factor: 3.633

Review 5.  Treatment of primary aldosteronism: Where are we now?

Authors:  Asterios Karagiannis
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

6.  The value of losartan suppression test in the confirmatory diagnosis of primary aldosteronism in patients over 50 years old.

Authors:  Chin-Chi Kuo; Poojitha Balakrishnan; Yenh-Chen Hsein; Vin-Cent Wu; Shih-Chieh Jeff Chueh; Yung-Ming Chen; Kwan-Dun Wu; Ming-Jiuh Wang
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2014-07-16       Impact factor: 1.636

7.  Persistent hypertension after adrenalectomy for an aldosterone-producing adenoma: weight as a critical prognostic factor for aldosterone's lasting effect on the cardiac and vascular systems.

Authors:  Yvette Carter; Madhuchhanda Roy; Rebecca S Sippel; Herbert Chen
Journal:  J Surg Res       Date:  2012-08-15       Impact factor: 2.192

8.  Adrenal venous sampling for primary aldosteronism and clinical outcomes after unilateral adrenalectomy: a single-center experience.

Authors:  Miho Murashima; Scott O Trerotola; Douglas L Fraker; Dale Han; Raymond R Townsend; Debbie L Cohen
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-06       Impact factor: 3.738

9.  Primary aldosteronism: from case detection to histopathology with up to 6 years of follow-up.

Authors:  Gudbjörg Jonsdottir; Jon Gudmundsson; Gudjon Birgisson; Helga Agusta Sigurjonsdottir
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-11-23       Impact factor: 3.738

10.  Endocrine hypertension: An overview on the current etiopathogenesis and management options.

Authors:  Reena M Thomas; Ewa Ruel; Prapimporn Ch Shantavasinkul; Leonor Corsino
Journal:  World J Hypertens       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.